Pathogenesis of Pulmonary Diseases
COPD is a slowly progressive condition characterized by airflow limitation, which is largely irreversible. It is characterized and defined by limitation of expiratory airflow. The current scenario is chronic airflow limitation results from an abnormal inflammatory response to inhaled particles and gases in the lung. The inflammatory mediators, including oxidants and proteases, are believed to play a major role in causing lung injury. Pathogenesis of COPD-an imbalance between proteases and antiproteases and an imbalance between oxidants and oxidative stress in the lungs. The pathological process of chronic lung disease is based on the concept that pulmonary diseases involve stages of commencement by pollutants, infectious agents and exposure to smoke, consolidation and progression. Tissue damage involves complex interactions among oxidative stress, chronic inflammation, extracellular matrix proteolysis, and apoptotic and autophagic cell death.
- Apoptosis
- Hyperinflation
- Inflammation
- Vasoconstriction
- Emphysema
Related Conference of Pathogenesis of Pulmonary Diseases
14th International Conference on COPD Clinical Trials & Lung Care Advances
18th International Conference on Chronic Obstructive Pulmonary Disease
16th International Conference on Pulmonary & Respiratory Medicine
7th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Pathogenesis of Pulmonary Diseases Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Acute Exacerbations and Intensive Care - COPD_2026 (UAE)
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- Advances in COPD Pharmacotherapy - COPD_2026 (UAE)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthama - Copd 2026 (France)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- Chronic Bronchitis - Copd 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Copd 2026 (France)
- Clinical Research and Translational Medicine - COPD_2026 (UAE)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Comorbidities and Multidisciplinary Care - COPD_2026 (UAE)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Epidemiology and Public Health - COPD_2026 (UAE)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pathogenesis and Molecular Mechanisms - COPD_2026 (UAE)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Phenotypes and Precision Medicine - COPD_2026 (UAE)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Coronavirus (COVID-19) - Copd 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - Copd 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Health, Telemedicine and Artificial Intelligence in COPD - COPD_2026 (UAE)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Early Diagnosis, Screening and Biomarkers - COPD_2026 (UAE)
- Emphysema - Copd 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Environmental Pollution and Occupational Lung Diseases - COPD_2026 (UAE)
- Future Innovations in COPD and Respiratory Healthcare - COPD_2026 (UAE)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional pulmonology - Copd 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Lung Cancer - Copd 2026 (France)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Imaging and Pulmonary Function Technologies - COPD_2026 (UAE)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia - Copd 2026 (France)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Arterial Hypertension - Copd 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation and Chronic Care - COPD_2026 (UAE)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections and Lung Microbiome - COPD_2026 (UAE)
- Respiratory Medicine and Pulmonology - COPD_2026 (UAE)
- Respiratory Tract Infections - Copd 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- Stages & Severity on Lung Diseases - Copd 2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
